| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.007 |